FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma

Objective: Multiple myeloma is an incurable hematological malignancy. It is imperative to identify immune markers for early diagnosis and therapy. Here, this study analyzed immune-related mRNAs and assessed their prognostic value and therapeutic potential. Methods: Abnormally expressed immune-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Haipeng, Zhang, Xiaofen, Liu, Xinxin, Qiao, Ruifang, Liu, Yan, Lv, Sulong, Zhu, Hongbo, Wang, Jie, Kong, Qiuhong, Zhang, Hong, Zhang, Zhirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266212/
https://www.ncbi.nlm.nih.gov/pubmed/34249967
http://dx.doi.org/10.3389/fmed.2021.667525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266212/
https://www.ncbi.nlm.nih.gov/pubmed/34249967
http://dx.doi.org/10.3389/fmed.2021.667525

Ejemplares similares